CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Agenus Inc  (AGEN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

AGEN's Revenue Year on Year Growth by Quarter and Year

Agenus Inc's Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
AGEN Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 5.58 7.64 1.62
III Quarter September - 4.45 6.85 1.56
II Quarter June - 6.59 6.38 3.07
I Quarter March 26.96 5.96 3.95 0.72
FY   26.96 22.58 24.82 6.97

Financial Statements
Agenus Inc's first quarter 2017 Revenue $ 26.96 millions AGEN's Income Statement
Agenus Inc's first quarter 2016 Revenue $ 5.96 millions Quarterly AGEN's Income Statement
AGEN's Growth by Division See AGEN's Growth by Segment

AGEN Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - -26.96 % 371.6 % 315.38 %
III Quarter September - -35.04 % 339.1 % 110.81 %
II Quarter June - 3.29 % 107.82 % 279.01 %
I Quarter March 352.28 % 50.89 % 448.61 % -35.14 %
FY   - -9.02 % 256.1 % -



AGEN Revenue Growth Comment
Agenus Inc achieved in the first quarter, above Company average Revenue surge of 352.28% year on year, to $ 26.96 millions.

Looking into first quarter results within Biotechnology & Drugs industry 5 other companies have achieved higher Revenue growth. While Agenus Inc' s Revenue doubling of 352.28% ranks overall at the positon no. 93 in the first quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #6
Healthcare Sector #24
S&P 500 #93
Revenue Y/Y Growth Statistics
High Average Low
448.42 % 125.79 % -91.71 %
(Mar 31 2015)   (Mar 31 2013)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AGEN's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for AGEN's Competitors
Revenue Growth for Agenus Inc's Suppliers
Revenue Growth for AGEN's Customers

You may also want to know
AGEN's Annual Growth Rates AGEN's Profitability Ratios AGEN's Asset Turnover Ratio AGEN's Dividend Growth
AGEN's Roe AGEN's Valuation Ratios AGEN's Financial Strength Ratios AGEN's Dividend Payout Ratio
AGEN's Roa AGEN's Inventory Turnover Ratio AGEN's Growth Rates AGEN's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Geovax Labs, Inc.  521.29 %$ 521.292 millions
Cytomx Therapeutics, Inc.  424.20 %$ 424.202 millions
Sientra, Inc.  409.11 %$ 409.109 millions
Sorrento Therapeutics, Inc.  393.32 %$ 393.320 millions
Bluebird Bio, Inc.  355.77 %$ 355.771 millions
Agenus Inc  352.36 %$ 352.365 millions
Protalix Biotherapeutics, Inc.  325.48 %$ 325.479 millions
Lifestyle Medical Network, Inc.  319.44 %$ 319.438 millions
Orexigen Therapeutics, Inc.  280.39 %$ 280.389 millions
Intellia Therapeutics, Inc.  249.75 %$ 249.747 millions
Biolargo, Inc.  230.06 %$ 230.060 millions
Corbus Pharmaceuticals Holdings, Inc.  226.20 %$ 226.199 millions
Exact Sciences Corp  226.01 %$ 226.006 millions
Accelerate Diagnostics, Inc.  225.15 %$ 225.153 millions
American Cryostem Corp  205.95 %$ 205.946 millions
Ionis Pharmaceuticals Inc  199.14 %$ 199.138 millions
Immune Design Corp.  193.34 %$ 193.344 millions
Transgenomic Inc  178.81 %$ 178.814 millions


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com